Gene Query: CLOCK

Dataset Description Geneva Score
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 52.81
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 52.81
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 43.19
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 37.74
Altering cancer transcriptomes using epigenomic inhibitors 37.74
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 32.11
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 28.86
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 27.18
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 25.43
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 25.19
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 24.23
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 22.87
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 20.97
RNAseq analysis of ESRP regulated splicing events in prostate cancer 20.2
LNCaP treated with iBET 20.02
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 18.73
RNA sequencing of matched nephrectomy samples [RNA-seq] 18.73
Functional role of SLIT2 and ROBO1 in trophoblasts 18.66
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 18.12
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 17.8
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 17.71
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 17.71
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 17.09
RNA sequencing of mechanically strained NHEKs and control NHEKs 17.02
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 16.98
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 16.8
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 16.59
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 16.3
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 16.3
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 16.17
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 15.84
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 15.44
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 15.08
hTERT promotes cell adhesion and migration independent of telomerase activity 13.86
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 13.85
Effect of disulfiram treatment on pediatric high grade glioma 13.36
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 13.23
Lysine benzoylation is a novel histone mark 13.07
Lysine benzoylation is a novel histone mark [RNA-seq] 13.07
TGF-β regulation of miRNA expression in pancreatic cancer 12.98
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 12.57
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 12.57
Electronic cigarettes 12.52
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 12.4
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 12.28
Transcriptomic analyssis following EHMT1/2 inhibition 11.65
Knockdown of ADNP in HCT116 colon cancer cells 11.46
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 11.19
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 11.15
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 11.15
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 10.9
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 10.89
HNF1 regulates critical functions of the human epididymis epithelium. 10.76
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 10.76
Region-specific Innate Antiviral Responses of the Human Epididymis 10.75
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 10.7
Neonatal and adult human testis defined at the single-cell level 10.59
Human cell line and subcutaneous tumor 10.57
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 10.51
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 10.39
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 10.39
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 10.3
AUF-1 affected genes in human skin cells 10.3
Tyrosine Kinase Inhibitor Cardiotoxicity 10.28
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 10.28
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 10.16
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 10.16
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 10.11
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 10.01
Regulation of highly expressed hCINAP on translatome 9.97
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 9.9
ChIP-seq and RNA-seq from human lymphoma cell lines 9.86
RNA-seq data from human lymphoma cell lines 9.86
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 9.85
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 9.85
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 9.83
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 9.83
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 9.82
Gene expression profiling of KSHV-infected periodontal ligament cells 9.81
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes 9.77
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 9.77
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 9.75
Ribosomal footprinting of CN34-Parental and CN34-LM1a 9.66
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 9.62
MYCi975 regulates MYC target genes 9.61
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 9.43
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 9.43
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 9.34
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 9.24
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 9.19
Gene expression changes caused by KRAS in MCF-10A 9.12
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 9.12
Silencing p300 in MCF7 cells to study expression and alternative splicing 9.12
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 9.08
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 9.08
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 9.07
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 9.05
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 9.05
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 9.03
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 9.03
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 9.01
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 9.01
FBXW7 modulates stress response by post-translational modification of HSF1 8.91
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 8.91
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 8.91
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 8.8
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 8.8
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 8.73
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 8.71
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 8.7
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 8.67
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 8.62
SUV420H2 knockdown in PANC-1 8.58
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 8.52
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 8.52
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 8.38
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 8.38
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 8.34
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 8.34
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 8.31
RNASeq of mouse, human, and non-human primate primary dermal fibroblasts to poly(I:C) transfection 8.29
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 8.29
Effect of CHKA knockdown on C4-2 cell transcriptome 8.26
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 8.25
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 8.24
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 8.17
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 8.17
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 8.17
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 8.13
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 8.08
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 8.05
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 8.04
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 7.99
Depicting early human development and germ cell origin with porcine embryos 7.93
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 7.92
Ribosomal footprinting of MDA-Parental and MDA-LM2 7.84
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 7.8
Expression level comparison under dividing and quiescent states in human primary fibroblasts 7.79
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 7.76
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 7.76
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 7.75
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 7.66
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 7.65
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 7.64
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 7.62
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 7.6
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 7.53
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 7.53
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 7.48
BAF controls genome accessibility 7.45
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 7.4
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 7.39
RNA seq analysis of human Fetal and adult derived Enterospheres 7.35
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 7.34
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 7.33
RNAseq Study in CC-671 Treated Cal-51 Cells 7.29
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 7.27
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 7.26
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 7.23
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 7.23
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 7.14
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 7.12
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 7.12
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 7.12
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 7.1
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 7.05
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 7.05
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 7.02
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 6.94
HNRNPM-regulated splicing dependencies in prostate cancer 6.94
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 6.9
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 6.9
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 6.9
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 6.87
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 6.86
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 6.85
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 6.85
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 6.76
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 6.74
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 6.72
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 6.69
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 6.67
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 6.62
High-throughput sequencing of PROMPT-enriched samples. 6.58
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 6.53
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 6.48
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes 6.47
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 6.46
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 6.42
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 6.42
Nucleoporin-mediated regulation of cell identity genes 6.4
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 6.39
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 6.37
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 6.37
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 6.37
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 6.32
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 6.32
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 6.24
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 6.22
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 6.21
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 6.2
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 6.17
Control of prostate tumour growth by the long non-coding RNA GHSROS 6.15
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 6.13
Effect of FGF13 depletion on the H460 cell line 6.13
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 6.06
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 6.03
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 5.99
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 5.98
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 5.96
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 5.94
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 5.94
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 5.93
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 5.9
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 5.89
SLAM-seq for K562 endogenous mRNA decay 5.89
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 5.89
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 5.89
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 5.87
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 5.83
Landscape and variation of RNA secondary structure across the human transcriptome 5.82
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 5.81
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 5.81
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 5.78
BCL11B 5.73
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 5.72
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 5.66
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 5.62
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 5.61
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 5.6
Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia 5.57
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 5.57
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 5.57
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 5.56
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 5.55
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 5.51
CDK12 mediated transcriptional regulation in U2OS cells 5.5
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 5.5
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 5.48
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 5.46
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 5.45
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 5.43
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 5.42
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 5.41
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 5.4
Mutational landscape of splicing genes and functional consequences across 33 cancer types 5.38
Splicing and epigenetic factors jointly regulate epidermal differentiation 5.38
STX4 Over-Expression in Human islets 5.38
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 5.37
LINE-2 transposable elements are a source of functional human microRNAs and target sites 5.35
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 5.32
RNA-seq of YB5 cells treated with Proscillaridin A 5.31
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 5.27
Global Mapping of Human RNA-RNA Interactions 5.26
The contribution of Alu exons to the human proteome 5.18
An siRNA screen identifies CHD4 as a target for epigenetic therapy 5.15
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 5.11
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 5.1
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 5.1
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 5.01
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 5.01
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 5.0
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 4.96
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 4.93
Role of COP1 on MAP kinase transcriptional output in melanoma 4.92
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 4.91
Recovery and analysis of nascent RNA 4.9
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 4.9
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 4.86
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 4.83
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 4.78
MYCL and EP400 are required for Max and MCPyV mediated gene activation 4.78
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 4.78
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 4.71
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 4.7
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 4.7
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 4.68
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 4.68
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 4.65
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 4.65
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 4.56
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 4.55
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 4.49
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 4.49
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 4.46
BET bromodomain inhibition 4.46
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 4.43
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 4.43
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 4.43
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 4.43
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 4.41
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 4.41
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 4.38
Targeted enhancer activation by a subunit of the integrator complex 4.36
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 4.34
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 4.28
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 4.23
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 4.21
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 4.17
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 4.14
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 4.12
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 4.08
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 4.08
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 3.98
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 3.97
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 3.95
UV_24h_GRO-Seq 3.95
Mammalian Hbs1L deficiency causes Pelota depletion and is associated with a unique phenotype 3.81
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 3.81
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 3.81
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 3.79
SLIGRL-induced gene expression changes in NHEK cells 3.77
miR-93 Targets in Human Endothelial Cells 3.77
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 3.74
Aneuploidy triggers an immune response 3.71
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 3.68
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 3.66
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 3.66
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 3.64
Searching for target genes of miR-508/509/506/514 in HCT116 cells 3.55
RNA-seq data 3.53
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 3.47
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 3.47
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 3.47
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 3.46
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 3.46
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 3.44
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 3.44
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 3.43
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 3.42
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) 3.4
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 3.38
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 3.37
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 3.36
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 3.36
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 3.28
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 3.27
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 3.25
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 3.23
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 3.23
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 3.21
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 3.17
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription [RNA-Seq] 3.13
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription 3.13
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 3.11
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 3.07
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 3.06
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 3.03
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 3.0
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 2.96
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 2.95
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 2.94
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 2.9
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 2.9
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 2.87
RNA-sequencing in immortalized human mammary epithelial cells 2.87
RNA Sequencing of Human iPS derived Cardiomyocytes 2.85
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 2.83
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 2.81
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 2.78
RNA-seq analysis of control and Myc-induced U2OS cells 2.78
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 2.73
DRB/GRO-Seq -/+ UV 2.7
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 2.68
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 2.68
Transcriptome of U251 cells overexpression complement component 7 2.54
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 2.53
Identification of long noncoding RNAs regulated by p53 2.48
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer 2.48
RNAseq in Alzheimer's Disease patients 2.43
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 2.38
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 2.33
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 2.33
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 2.3
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 2.3
Conservative alteration of chromosomal expression pattern across human solid tumor types 2.28
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 2.25
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 2.24
RNA sequencing analysis of selumetinib-resistant CRC cells lines 2.23
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 2.22
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 2.22
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 2.17
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 2.13
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 2.13
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 2.11
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 2.1
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 2.1
Analysis of transcriptional regulation by Myt1 and Myt1l 2.09
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 2.03
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 2.03
Gene expression analysis of human hepatocellular cancers 2.02
Finding missing proteins from epigenetically manipulated human cells 2.01
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 1.99
The circadian transcriptional landscape in primary human mammary epithelial cells 1.96
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 1.95
RNA-seq of MDA-MB-231 cells with TET1 knockout 1.93
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 1.81
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 1.79
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 1.79
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 1.76
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 1.75
Dilated cardiomyopathy vs Myocarditis 1.66
Interphase condensins regulate ligand-depedent enhancer activation 1.62
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 1.62
Evolutionary origin and functional divergence of stem cell homeobox genes in eutherian mammals 1.62
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 1.61
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 1.61
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 1.6
Myc activation coordinates gene transcription and protein translation responses 1.59
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 1.56
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 1.55
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 1.55
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 1.55
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 1.54
Regulatory network controlling tumor-promoting inflammation in human cancers 1.54
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 1.51
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 1.45
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 1.43
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 1.39
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 1.33
A code of mono-phosphorylation modulates the function of RB. 1.26
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 1.18
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 1.14
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 1.14
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 1.13
The role of the Calcium-Sensing receptor in colorectal cancer 1.11
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 1.05
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 1.05
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 1.05
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 1.05
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 1.05
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 1.04
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.95
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.95
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.92
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.92
RNA seq comparison between scrambled and shGRP78 cells 0.89
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 0.88
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.88
Transcriptome-wide response to synthetic chromatin protein PcTF 0.87
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 0.81
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 0.81
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 0.8
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 0.79
Transcriptomes in healthy and CHB fetal hearts 0.76
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 0.74
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 0.74
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 0.73
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.73
HBEC-shp53-PCHD7 0.67
Gene expression analysis of a panel of human fibroblasts that generate an aligned (anisotropic) vs non-aligned extracellular matrix 0.67
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 0.67
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.65
Deletions in the ATAD3 gene cluster cause cerebellar developmental defects with mitochondrial DNA abnormalities owing to local cholesterol insufficiency 0.64
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.63
Investigate A2M treatment on human prostate cancer and mouse liver 0.62
Investigate A2M treatment on human prostate cancer xenograft in mice 0.62
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 0.59
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 0.59
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.56
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.56
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 0.54
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 0.53
Effects of transcription on genome - nuclear lamina interactions 0.53
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 0.53
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 0.53
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 0.49
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.48
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 0.47
nELAVL HITS-CLIP in Alzheimer's Disease patients 0.47
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 0.46
Metastasis in triple-negative breast cancer 0.45
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 0.45
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.42
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 0.36
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 0.36
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 0.36
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 0.35
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 0.35
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 0.34
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.33
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 0.33
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 0.31
RNA-Seq from human ILC transitional populations 0.31
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 0.31
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 0.31
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.27
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.27
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 0.23
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 0.23
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.18
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 0.17
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 0.16
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 0.1
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 0.08
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 0.04
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 0.04
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.03
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.03
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation